Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid bronchial passageways of bothersome mucus
helps loosen phlegm (mucus) and thin bronchial secretions to rid bronchial passageways of bothersome mucus
take every 4 hours do not exceed 6 doses in 24 hours adults & children 12 years and over 10 mL - 20 mL (2 - 4 teaspoonfuls) children 6 years to under 12 years 5 mL - 10 mL (1 - 2 teaspoonfuls) children 2 years to under 6 years 2.5 mL - 5 mL (½ - 1 teaspoonful) children under 2 years ask a doctor
Guaifenesin 100 mg
Expectorant
These could be signs of a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults & children 12 years and over | 10 mL - 20 mL (2 - 4 teaspoonfuls) |
| children 6 years to under 12 years | 5 mL - 10 mL (1 - 2 teaspoonfuls) |
| children 2 years to under 6 years | 2.5 mL - 5 mL (½ - 1 teaspoonful) |
| children under 2 years | ask a doctor |
Acesulfame K, artificial cherry flavor, artificial vanilla flavor, aspartame, hypromellose, menthol, methylparaben, potassium sorbate, purified water. Citric acid may be used to adjust pH.
Call 1-800-899-3116, Mon-Thurs 9:00 am - 5:00 pm EST, Fri 9:00 am - 2:30 pm EST. Serious side effects associated with use of this product may be reported to this number.
Rev #063:05 10/11
City of Austin Dept of Health
GUAIFENESIN
118ml
Date:
Name:
Dr.
TAKE AS DIRECTED.
1/1/01
123456
GUAIFENESIN 118ml NDC 76413-335-01
Batch: 123456
Lot: 123456
Exp: 1/1/01
AKORN
Federal law prohibits the transfer of this drug to any other person than the patient for whom prescribed.

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 992212 | Diabetic Tussin Expectorant 100 MG in 5 mL Oral Solution | PSN | 1 |
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 1 |
| 992212 | guaifenesin 20 MG/ML Oral Solution [Diabetic Tussin EX] | SBD | 1 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 1 |
| 992212 | Diabetic Tussin EX 20 MG/ML Oral Solution | SY | 1 |
| 992212 | Diabetic Tussin Expectorant 100 MG per 5 ML Oral Solution | SY | 1 |
| 992212 | Diabetic Tussin Mucus Relief 20 MG/ML Oral Solution | SY | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 1 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 1 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 1 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76413-335-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-340f-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76413-335-01 | Diabetic Tussin Expectorant | 118 mL in 1 BOTTLE | LIQUID | 118 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61787-063-04 | ML - Milliliter | 61787-063 | 471a5c43-e04c-4129-9e98-8431db079406 | 1 | 2012-07-24 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76413-335 | 76413-335-01 |
| 61787-063 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GUAIFENESIN | 495W7451VQ | ACTIB |
| ACESULFAME POTASSIUM | 23OV73Q5G9 | IACT |
| ASPARTAME | Z0H242BBR1 | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MENTHOL, UNSPECIFIED FORM | L7T10EIP3A | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| WATER | 059QF0KO0R | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 494c896e-9a61-4e4a-b301-c81e97ba7bd7 | 18f4c0c4-4448-470c-bd82-8d6cd3f8cd71 | 2017-08-15 | Warnings | 494c896e-9a61-4e4a-b301-c81e97ba7bd7 18f4c0c4-4448-470c-bd82-8d6cd3f8cd71 |
Adverse event summaries are temporarily unavailable. Other product information remains available.